Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression

Biological Psychiatry

Volumn 44, Issue 5, 1998, Pages 348-360

  Keller, Martin B ^a,b,d   Boland, Robert J ^a,c  

^a BROWN UNIVERSITY   (United States)

^b BUTLER HOSPITAL   (United States)

^c MIRIAM HOSPITAL   (United States)

^d Brown Affiliated Hospitals (MBK)   (United States)

Author keywords

Course of depression; Depression; Maintenance treatment

Indexed keywords

CITALOPRAM; FLUOXETINE; IMIPRAMINE; LITHIUM CARBONATE; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEALTH CARE SYSTEM; HUMAN; JOB PERFORMANCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL HEALTH CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; RECURRENCE; TIME FACTORS; TREATMENT FAILURE;

EID: 0031713540     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00110-3     Document Type: Review

References (45)

1. Angst J. The course of major depression, atypical bipolar disorder, and bipolar disorder. Hippius H., Kleman G.L., Matussek N. New Results in Depression Research. 1986;26-35 Springer-Verlag, Berlin/Heidelberg.
2. Angst J., Baastrup P., Grof, et al. The course of monopolar depression and bipolar psychoses. Psychiatr Neurol Neurochir. 76:1973;489-500.
3. Boland R.J., Keller M.B. Outcome studies of depression in adulthood. Shulman K.I., Tohen J., Kutcher S.P. Mood Disorders across the Life Span. 1996;217-250 Wiley, New York.
4. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord. 43:1997;27-39.
5. NIMH/NIH Consensus Development Conference Statement. Mood disorders Pharmacological prevention of recurrences . Am J Psychiatry. 142:1985;469-476.
6. Doogan D.P., Caillard V. Sertraline in the prevention of depression. Br J Psychiatry. 160:1992;217-222.
7. Frank E., Kupfer D.J., Perel J.M., et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 47:1990;1093-1099.
8. Frank E., Prien R.F., Jarrett R.B., et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder Remission, recovery, relapse, and recurrence . Arch Gen Psychiatry. 48:1991;851-855.
9. Frank E., Kupfer D.J., Perel J.M., et al. Comparison of full dose versus half dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord. 27:1993;139-145.
10. Guy W, editor (1976): ECDEU Assessment Manual for Psychopharmacology (Publication ADM 76-338). Washington, DC: US Department of Health, Education, and Welfare.
11. Guze S.B., Robins E. Suicide and primary affective disorders. Br J Psychiatry. 117:1970;437-438.
12. Hamilton M.A. A rating scale of depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
13. Hirschfield R.M.A., Keller M.B., Panico S., et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 277:1997;333-340.
14. Hwu H.-G., Yeh I.K., Chang L.Y. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand. 79:1989;136-147.
15. Judd LL, Akiskal HS, Maser JD, et al (1998): A prospective 12 year study of subsyndromal and syndromal depressive symptomatology in unipolar major depressive disorder. Arch Gen Psychiatry (in press).
16. Katz M., Klerman G.L. Introduction Overview of the clinical studies program . Am J Psychiatry. 136:1979;49-51.
17. Keller M.B. Depression underrecognition and undertreatment by psychiatrists and other health care professionals. Arch Intern Med. 150:1990;946-948.
18. Keller M.B. The difficult depressed patient in perspective. J Clin Psychiatry. 54:(suppl 2):1993;4-9.
19. Keller MB (1995): The role of continuation treatment in chronic depression. Paper presented at the meeting of the European College of Neuropsychopharmacology, 8th annual Congress, Venice, Italy, October.
20. Keller M.B., Shapiro R.W. "Double depression" Superimposition of acute depressive episodes on chronic depressive disorders . Am J Psychiatry. 139:1982;438-442.
21. Keller M.B., Shapiro R., Lavori P.W., et al. Recovery in major depressive disorder Analysis with the life table and regression models . Arch Gen Psychiatry. 39:1982;905-910.
22. Keller M.B., Klerman G.L., Lavori P.W., et al. Treatment received by depressed patients. JAMA. 248:1982;1848-1855.
23. Keller M.B., Lavori P.W., Lewis C.E., Klerman G.L. Predictors of relapse in major depressive disorder. JAMA. 2509:1983;3299-3304.
24. Keller M.B., Klerman G.L., Lavori P.W., Coryell W., Endicott J., Taylor J. Long-term outcome of episodes of major depression Clinical and public health significance . JAMA. 252:1984;788-792.
25. Keller M.B., Lavori P.W., Rice J., Coryell W., Hirschfield R.M.A. The persistent risk of chronicity in recurrent episodes of non-bipolar major depressive disorder A prospective follow-up . Am J Psychiatry. 143:1984;24-28.
26. Keller M.B., Lavori P.W., Klerman G.L., et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry. 43:1986;458-466.
27. Keller M.B., Lavori P.W., Mueller T.I., et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 49:1992;809-816.
28. Keller MB, Kocsis J, McCullough J, et al (1997): Sertraline Maintenance Treatment of Recurrent Chronic Depression. Poster session presented at the annual meeting of the American Psychiatric Association, San Diego, CA.
29. Keller MB, Keitner G, Miller IW, et al (1997): Acute, continuation, crossover and maintenance study of the treatment of chronic major depression and double depression, comparing cognitive-behavior therapy (CBT) alone, nefazodone alone, and the combination of CBT and nefazodone. Bristol-Myers Squibb sponsored study. Unpublished data.
30. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States Results from the National Comorbidity Survey . Arch Gen Psychiatry. 51:1994;8-19.
31. Kupfer D.J., Frank E., Perel J.M., et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 49:1992;769-773.
32. Lavori P.W., Keller M.B., Scheftner, et al. Recurrence after recovery in unipolar major depressive disorder An observational follow-up study of clinical predictors and somatic treatment as a mediating factor . Int J Methods Psychiatr Res. 4:1994;211-229.
33. Montgomery SA, Dunbar G (1993): Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 8:189-19.
34. Montgomery S.A., Dunfour H., Brion S., et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry. 153:(suppl 3):1988;69-76.
35. Montgomery S.A., Rasmussen J.G., Tanghoj P. A 24-week study of 20 mg citalopram, 40 mg citalopram and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol. 8:1993;181-188.
36. Mueller T.I., Keller M.B., Leon A., et al. Recovery after five years of unremitting major depressive disorder. Arch Gen Psychiatry. 53:1996;794-799.
37. Murray CJL, Lopez AD (1996): The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020 Global Burden of Disease and Injury Series, vol 1). Boston, MA: Harvard University Press.
38. Pfeffer C.R., Klerman G.L., Hurt S.W., Lesser M., Peskin J.R., Siefker C.A. Suicidal children grow up Demographic and clinical risk factors for adolescent suicide attempts . J Am Acad Child Adolesc Psychiatry. 30:1991;609-616.
39. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 149:1992;999-1010.
40. Prien R.F., Kupfer D.J., Mansky P.A., et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry. 41:1984;1096-1104.
41. Robins L.N., Kulbok P.A. Epidemiologic studies in suicide. Frances A.J., Hales R.E. Suicide Volume 7, Review of Psychiatry . 1988;289-306 American Psychiatric Press, Washington, DC.
42. Singh G.K., Yu S.M. Trends and differentials in adolescent and young adult mortality in the United States, 1950 through 1993. Am J Public Health. 86:1996;560-564.
43. Solomon D.A., Keller M.B., Leon A.C. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry. 54:1997;1001-1006.
44. Weissman M.M. The changing rate of major depression Cross-national comparisons . JAMA. 268:1992;3098-3105.
45. Wells K.B., Steward A., Hays R.D., et al. The functioning and well-being of depressed patients Results of the Medical Outcomes Study . JAMA. 262:1989;914-919.